COVID-19: Talking Next-Gen Diagnostics
Sponsor: SynthegoListen to the science writing talent from GEN in the second "GEN LIVE" interactive conversation on the latest science and medical news from the frontlines of the COVID-19 pandemic. In Episode 2 GEN editors Julianna LeMieux, Alex Philippidis and Kevin Davies will discuss the latest advances in COVID-19 diagnostics. This episode features Janice Chen, PhD, co-founder of Mammoth Biosciences and Jonathan Rothberg, PhD, CSO of 4Catalyzer.
Association Rate Constant: The Unsung Hero of Drug Discovery Kinetics
Sponsor: CisbioWhile the importance of ligand-receptor binding kinetics on drug action is becoming well established, focus to date has been almost entirely on the role of the dissociation constant on drug efficacy and duration of action. The association rate constant, in contrast, has been largely overlooked, with many investigators still considering it diffusion-limited and equivalent across a compound series. This GEN webinar aims to remedy that by turning the spotlight onto the undervalued and oft-ignored association rate constant.
The Empowerment of Having a Lab of One’s Own: Continued Research...
Sponsor: Horizon Discovery and OnRamp BioIn this webinar—the second in the “Women in Science” series co-hosted by GEN and the Rosalind Franklin Society—pioneering microbiologist and the first woman to lead the National Science Foundation, Rita Colwell, PhD, discusses her early work in bacteriology and discoveries about how cholera survives between epidemics, with its continuing relevance today in addressing contagion, ocean science , and climate change.
Rapid Discovery of Functional Antibodies for SARS-CoV-2 Using the Beacon System
Sponsor: Berkeley LIghtsIn this GEN webinar, sponsored by Berkeley Lights, we will hear from Anupam Singhal, PhD, who will provide a brief overview of how antibody discovery on the Beacon optofluidic system can be used to screen human B cells for the discovery of antiviral antibodies in under one week. Robert Carnahan, PhD, and Seth Zost, PhD, from the Vanderbilt University Medical Center, will then describe how they have used the Beacon system, to rapidly discover hundreds of unique antibodies against SARS-CoV-2.
The Future of Cellular Immunotherapy: Highly Automated Precision Medicine
Sponsor: IsoPlexisIn this GEN webinar, learn how Lonza’s Cocoon™ cell therapy manufacturing platform and IsoPlexis’ IsoLight™ single-cell proteomics system can be used together to advance the future of cancer immunotherapy.
Measuring Multivalent Interactions: Uncovering the Secrets of Virus Binding Strategies
Sponsor: NanotemperIn this GEN webinar, we will learn from Dr. Daniel Lauster, who, when faced with many of the challenges described above, utilized MicroScale Thermophoresis (MST) to measure the interaction between more than 100 novel non-toxic multivalent nanoparticle-conjugates and intact IAV in solution with as little as nanomoles of nanoparticles. Additionally, we will hear from Dr. Matthias Molnar how MST is becoming scientists’ first choice for the characterization of molecular interactions thanks to its flexible throughput, low sample consumption, and measurements in solution or in close to native conditions.
The Secret to Improving the Therapeutic Index of Antibody Drug Conjugates
Sponsored by: 3DS Dassault Systemes
REGISTER NOW
Broadcast Date: February 5, 2019
Time: 8:00 am PT, 11:00 am ET, 17:00 CET
Antibody-drug conjugates (ADCs) were initially developed to provide a selective targeting...
Recent Advances and the Future of Antibody Engineering
Sponsor: Bio-techneIn this GEN webinar, we will hear from Danica Stanimirovic MD, PhD, and Danica Stanimirovic MD, PhD, wto leading scientists who will describe their current antibody engineering research projects and the therapeutic potential they hold.
Streamlining High-Throughput Impurity Analysis in Process Development
Sponsor: LonzaIn this GEN webinar, we will hear about some of the latest advances in high-throughput analytics, with particular attention on the High-Throughput Impurity Detection platform for automated impurity quantitation from Lonza.
Reliable Single Cell Outgrowth: Dark Art or Science?
Sponsor: SolentimIn this GEN webinar, we will discuss how the VIPS™ (Verified in-situ Plate Seeding) system, in combination with the SAL Scientific single-cell cloning supplements, offer customers a high-efficiency solution which ensures plates are populated with high numbers of healthy single cells that grow into resultant colonies for screening, expansion and further selection to master cell banks.
Explore
Advertise
Copyright © 2021 Genetic Engineering & Biotechnology News. All Rights Reserved.
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our privacy policy.